{"date":"2026-03-30","count":58,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6659-2026-03-30-2028-11pb9eh","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:28:03","subject":"補公告代孫公司湖北香連藥業有限責任公司公告辦理現金減資案。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-03-30 20:28，「補公告代孫公司湖北香連藥業有限責任公司公告辦理現金減資案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-03-30-2022-19axs2p","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:22:51","subject":"公告本公司代理發言人異動。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-03-30 20:22，「公告本公司代理發言人異動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-03-30-2022-dq37dv","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:22:09","subject":"公告本公司董事會通過114年度財務報表。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-03-30 20:22，「公告本公司董事會通過114年度財務報表。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-30-2022-1howjn","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:22:02","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-30 20:22，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-30-2020-bwopfv","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:20:29","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-30 20:20，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-30-2019-5rax5d","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:19:57","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-30 20:19，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-30-2018-33gqv","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:18:41","subject":"公告本公司董事會通過設置策略長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-30 20:18，「公告本公司董事會通過設置策略長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-30-2017-q1wnzv","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:17:06","subject":"公告本公司董事會通過總經理異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-30 20:17，「公告本公司董事會通過總經理異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-30-2016-f6b555","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:16:26","subject":"公告本公司董事會決議辦理115年度第一次現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-30 20:16，「公告本公司董事會決議辦理115年度第一次現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-30-2015-drgvb6","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:15:12","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-30 20:15，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-30-2014-5j9yh6","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:14:38","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-30 20:14，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-03-30-2008-13nexuv","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"20:08:47","subject":"公告本公司董事會通過115年股東常會相關事宜。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-03-30 20:08，「公告本公司董事會通過115年股東常會相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-03-30-1943-tvxd02","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"19:43:26","subject":"董事會決議股利分派。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-03-30 19:43，「董事會決議股利分派。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-03-30-1911-xsjn55","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"19:11:50","subject":"公告本公司董事會決議召開115年股東常會及相關事宜(新增議案)","clause":"第32款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-03-30 19:11，「公告本公司董事會決議召開115年股東常會及相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-03-30-1911-6xa2xa","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"19:11:13","subject":"公告本公司終止與新加坡Senectus公司經銷與臨床研究合作合約","clause":"第8款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-03-30 19:11，「公告本公司終止與新加坡Senectus公司經銷與臨床研究合作合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-03-30-1910-2iz4hx","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"19:10:36","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-03-30 19:10，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-03-30-1910-qdzqle","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"19:10:00","subject":"公告本公司董事會決議變更113年現金增資之資金運用計畫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-03-30 19:10，「公告本公司董事會決議變更113年現金增資之資金運用計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-03-30-1909-ty20fv","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"19:09:21","subject":"公告本公司董事會決議辦理現金增資私募普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-03-30 19:09，「公告本公司董事會決議辦理現金增資私募普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-03-30-1908-d1j5l0","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"19:08:58","subject":"代子公司Bio-Nutri co., ltd 依公開發行公司資金貸與及 背書保證處理準則第二十二條第一項第三款公告","clause":"第23款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-03-30 19:08，「代子公司Bio-Nutri co., ltd 依公開發行公司資金貸與及 背書保證處理準則第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-03-30-1908-5j9yh6","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"19:08:41","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-03-30 19:08，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-03-30-1900-1pa4gh","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"19:00:03","subject":"本公司安拓伏腸病毒71型疫苗(EnVAX-A71)通過澳門藥物監督管理局「藥物(西藥)」新藥查驗登記核准，取得腸病毒疫苗藥證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-03-30 19:00，「本公司安拓伏腸病毒71型疫苗(EnVAX-A71)通過澳門藥物監督管理局「藥物(西藥)」新藥查驗登記核准，取得腸病毒疫苗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-03-30-1857-bwopfv","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"18:57:49","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-03-30 18:57，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-03-30-1844-1dd9qx8","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"18:44:31","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"第32款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-03-30 18:44，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-30-1819-m99b0b","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-30","time":"18:19:06","subject":"代100%持有之子公司沛(月太)(上海)醫藥科技有限公司公告，本公司研發針對類風濕關節炎(RA)之口服新藥PP011，向中國國家藥品監督管理局(NMPA)遞交第一期臨床試驗許可申請(IND)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-30 18:19，「代100%持有之子公司沛(月太)(上海)醫藥科技有限公司公告，本公司研發針對類風濕關節炎(RA)之口服新藥PP011，向」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-03-30-1818-5j9yh6","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"18:18:59","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第9款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-03-30 18:18，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-03-30-1816-bwopfv","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"18:16:49","subject":"公告本公司董事會決議不分派股利","clause":"第9款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-03-30 18:16，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-03-30-1815-1howjn","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"18:15:08","subject":"公告本公司董事會決議召開115年股東常會","clause":"第9款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-03-30 18:15，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-03-30-1751-1b89la1","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:51:05","subject":"公告本公司董事會通過114年度財務報告","clause":"第43款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-03-30 17:51，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-03-30-1746-g30ifu","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:46:35","subject":"本公司董事會決議114年度不分配股東紅利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-03-30 17:46，「本公司董事會決議114年度不分配股東紅利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-03-30-1743-1db57u6","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:43:43","subject":"本公司114年度財務報告經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-03-30 17:43，「本公司114年度財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-03-30-1743-1e838vk","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:43:15","subject":"本公司董事會決議召開115年股東常會公告相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-03-30 17:43，「本公司董事會決議召開115年股東常會公告相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-03-30-1740-1ctgck9","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:40:31","subject":"本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-03-30 17:40，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-03-30-1738-10jca0t","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:38:08","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-04-13","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-03-30 17:38，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-03-30-1737-fqsc9p","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:37:34","subject":"本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-03-30 17:37，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-03-30-1735-u9tudf","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:35:52","subject":"本公司董事會通過擬辦理現金增資供初次上市(櫃)公開承銷，請原股東全數放棄認購案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-03-30 17:35，「本公司董事會通過擬辦理現金增資供初次上市(櫃)公開承銷，請原股東全數放棄認購案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-03-30-1735-1stc4f8","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:35:27","subject":"本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-03-30 17:35，「本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-03-30-1735-foexgn","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:35:02","subject":"本公司董事會決議通過114年度財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-03-30 17:35，「本公司董事會決議通過114年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-30-1716-1fry2sp","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-30","time":"17:16:35","subject":"公告本公司股票初次上市前現金增資員工認購股款催繳事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-30 17:16，「公告本公司股票初次上市前現金增資員工認購股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-30-1710-m2f5r7","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-30","time":"17:10:50","subject":"董事會決議通過變更獨立董事候選人名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-30 17:10，「董事會決議通過變更獨立董事候選人名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-03-30-1710-iz95d6","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:10:04","subject":"公告本公司董事會決議通過114年度虧損撥補案及無分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-03-30 17:10，「公告本公司董事會決議通過114年度虧損撥補案及無分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-03-30-1703-v47tfz","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-30","time":"17:03:46","subject":"公告本公司董事會通過115年股東常會召開相關事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-30 17:03，「公告本公司董事會通過115年股東常會召開相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-03-30-1703-nwb9x0","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:03:37","subject":"代重要子公司育禾管理顧問股份有限公司公告董事會決議114年度累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-03-30 17:03，「代重要子公司育禾管理顧問股份有限公司公告董事會決議114年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-03-30-1703-ae1eci","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:03:14","subject":"公告本公司董事會決議召開115年度股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-03-30 17:03，「公告本公司董事會決議召開115年度股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-03-30-1703-506hbw","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"17:03:11","subject":"代重要子公司育禾管理顧問股份有限公司公告董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-03-30 17:03，「代重要子公司育禾管理顧問股份有限公司公告董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-03-30-1644-drgvb6","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"16:44:56","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-03-30 16:44，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-03-30-1639-1oamt6j","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"16:39:10","subject":"公告本公司董事會決議114年度不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-03-30 16:39，「公告本公司董事會決議114年度不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-03-30-1617-1r2l9ai","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"16:17:16","subject":"代重要子公司新普利(股)公司公告董事會決議一一四年度股利分派之除息基準日","clause":"第14款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-03-30 16:17，「代重要子公司新普利(股)公司公告董事會決議一一四年度股利分派之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-03-30-1616-6oc518","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"16:16:54","subject":"代重要子公司台灣味群工業股份有限公司公告董事會重要決議事項","clause":"第53款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-03-30 16:16，「代重要子公司台灣味群工業股份有限公司公告董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-03-30-1616-duhtlq","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"16:16:27","subject":"代重要子公司台灣味群工業股份有限公司公告董事會決議召開115年股東會相關事宜—新增議案","clause":"第17款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-03-30 16:16，「代重要子公司台灣味群工業股份有限公司公告董事會決議召開115年股東會相關事宜—新增議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-03-30-1616-bv8d3x","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"16:16:04","subject":"代重要子公司台灣味群工業股份有限公司公告董事會決議股利分配","clause":"第14款","fact_date":"2026-03-30","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-03-30 16:16，「代重要子公司台灣味群工業股份有限公司公告董事會決議股利分配」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-03-30-1604-vsk5u","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"16:04:10","subject":"公告本公司董事會通過民國114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-03-30 16:04，「公告本公司董事會通過民國114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-03-30-1545-1hdezzy","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"15:45:33","subject":"公告本公司董事會決議不分配114年度員工酬勞及董事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-03-30 15:45，「公告本公司董事會決議不分配114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-03-30-1533-1b89la1","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-03-30","time":"15:33:39","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-03-30 15:33，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-03-30-1509-uhe5fz","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"15:09:02","subject":"公告本公司董事會通過113年現金增資資金運用計畫變更","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-03-30 15:09，「公告本公司董事會通過113年現金增資資金運用計畫變更」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-03-30-1508-ffwofu","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"15:08:15","subject":"公告本公司董事會決議與上海醫藥集團股份有限公司簽訂LT3001急性缺血性腦中風中國大陸授權合約之增修協議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-03-30 15:08，「公告本公司董事會決議與上海醫藥集團股份有限公司簽訂LT3001急性缺血性腦中風中國大陸授權合約之增修協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-03-30-1506-17bo3qr","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"15:06:15","subject":"公告本公司與天士力醫藥集團股份有限公司簽訂AP505合作補充協議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-03-30 15:06，「公告本公司與天士力醫藥集團股份有限公司簽訂AP505合作補充協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-30-1441-k4pxn2","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"14:41:56","subject":"公告本公司董事會決議第二次買回庫藏股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-30 14:41，「公告本公司董事會決議第二次買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-03-30-1144-1fqkmsr","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-03-30","time":"11:44:36","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-03-30 11:44，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}